[go: up one dir, main page]

BR9912587A - Processo sistema e dispositivo para realçar a absorção celular de uma substância, processos para realçar a transfecção de gene de um gene transferido para uma região alvo do corpo de um paciente e para promover a angiogênese em membros isquêmicos, e, kit - Google Patents

Processo sistema e dispositivo para realçar a absorção celular de uma substância, processos para realçar a transfecção de gene de um gene transferido para uma região alvo do corpo de um paciente e para promover a angiogênese em membros isquêmicos, e, kit

Info

Publication number
BR9912587A
BR9912587A BR9912587-0A BR9912587A BR9912587A BR 9912587 A BR9912587 A BR 9912587A BR 9912587 A BR9912587 A BR 9912587A BR 9912587 A BR9912587 A BR 9912587A
Authority
BR
Brazil
Prior art keywords
enhancing
target region
substance
patient
gene
Prior art date
Application number
BR9912587-0A
Other languages
English (en)
Inventor
Alex Brisken
Robert Zuk
John Mckenzie
Jeff Isner
Meno Nassi
Original Assignee
Pharmasonics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/126,011 external-priority patent/US6464680B1/en
Application filed by Pharmasonics Inc filed Critical Pharmasonics Inc
Publication of BR9912587A publication Critical patent/BR9912587A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0092—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

"PROCESSO. SISTEMA E DISPOSITIVO PARA REALçAR A ABSORçãO CELULAR DE UMA SUBSTâNCIA, PROCESSOS PARA REALçAR A TRANSFECçãO DE GENE DE UM GENE TRANSFERIDO PARA UMA REGIãO ALVO DO CORPO DE UM PACIENTE E PARA PROMOVER A ANGIOGêNESE EM MEMBROS ISQUêMICOS E, KIT". A invenção é um processo de realçar a absorção celular de uma substância liberada em uma região alvo do corpo de um paciente, que compreende transferir a substância ( 21 ) para a região alvo ( 22 ) e direcionar energia vibracional ( 32 ) para a região alvo, em que a energia vibracional é de um tipo e em uma quantidade suficiente para realçar a absorção nas células ( 24 ) da região alvo.
BR9912587-0A 1998-07-29 1999-07-29 Processo sistema e dispositivo para realçar a absorção celular de uma substância, processos para realçar a transfecção de gene de um gene transferido para uma região alvo do corpo de um paciente e para promover a angiogênese em membros isquêmicos, e, kit BR9912587A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/126,011 US6464680B1 (en) 1998-07-29 1998-07-29 Ultrasonic enhancement of drug injection
US25529099A 1999-02-22 1999-02-22
PCT/US1999/017305 WO2000006032A1 (en) 1998-07-29 1999-07-29 Ultrasonic enhancement of drug injection

Publications (1)

Publication Number Publication Date
BR9912587A true BR9912587A (pt) 2002-06-11

Family

ID=26824191

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9912587-0A BR9912587A (pt) 1998-07-29 1999-07-29 Processo sistema e dispositivo para realçar a absorção celular de uma substância, processos para realçar a transfecção de gene de um gene transferido para uma região alvo do corpo de um paciente e para promover a angiogênese em membros isquêmicos, e, kit

Country Status (6)

Country Link
EP (1) EP1107702A4 (pt)
JP (1) JP2002521118A (pt)
AU (1) AU754022B2 (pt)
BR (1) BR9912587A (pt)
CA (1) CA2338396A1 (pt)
WO (1) WO2000006032A1 (pt)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6050943A (en) 1997-10-14 2000-04-18 Guided Therapy Systems, Inc. Imaging, therapy, and temperature monitoring ultrasonic system
AU3597100A (en) * 1999-02-22 2000-09-04 Pharmasonics, Inc. Methods and apparatus for uniform transcutaneous therapeutic ultrasound
US7914453B2 (en) 2000-12-28 2011-03-29 Ardent Sound, Inc. Visual imaging system for ultrasonic probe
US6623444B2 (en) * 2001-03-21 2003-09-23 Advanced Medical Applications, Inc. Ultrasonic catheter drug delivery method and device
US20030147812A1 (en) * 2001-12-11 2003-08-07 Friedrich Ueberle Device and methods for initiating chemical reactions and for the targeted delivery of drugs or other agents
US7358226B2 (en) * 2003-08-27 2008-04-15 The Regents Of The University Of California Ultrasonic concentration of drug delivery capsules
US9011336B2 (en) 2004-09-16 2015-04-21 Guided Therapy Systems, Llc Method and system for combined energy therapy profile
US7824348B2 (en) 2004-09-16 2010-11-02 Guided Therapy Systems, L.L.C. System and method for variable depth ultrasound treatment
US7393325B2 (en) 2004-09-16 2008-07-01 Guided Therapy Systems, L.L.C. Method and system for ultrasound treatment with a multi-directional transducer
US8444562B2 (en) 2004-10-06 2013-05-21 Guided Therapy Systems, Llc System and method for treating muscle, tendon, ligament and cartilage tissue
US10864385B2 (en) 2004-09-24 2020-12-15 Guided Therapy Systems, Llc Rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US8535228B2 (en) 2004-10-06 2013-09-17 Guided Therapy Systems, Llc Method and system for noninvasive face lifts and deep tissue tightening
US8133180B2 (en) 2004-10-06 2012-03-13 Guided Therapy Systems, L.L.C. Method and system for treating cellulite
US11883688B2 (en) 2004-10-06 2024-01-30 Guided Therapy Systems, Llc Energy based fat reduction
US9694212B2 (en) 2004-10-06 2017-07-04 Guided Therapy Systems, Llc Method and system for ultrasound treatment of skin
US7758524B2 (en) 2004-10-06 2010-07-20 Guided Therapy Systems, L.L.C. Method and system for ultra-high frequency ultrasound treatment
US20060111744A1 (en) 2004-10-13 2006-05-25 Guided Therapy Systems, L.L.C. Method and system for treatment of sweat glands
DE202005022028U1 (de) 2004-10-06 2012-07-09 Guided Therapy Systems, Llc System zur Ultraschallgewebebehandlung
US9827449B2 (en) 2004-10-06 2017-11-28 Guided Therapy Systems, L.L.C. Systems for treating skin laxity
US8690779B2 (en) 2004-10-06 2014-04-08 Guided Therapy Systems, Llc Noninvasive aesthetic treatment for tightening tissue
JP2008522642A (ja) 2004-10-06 2008-07-03 ガイデッド セラピー システムズ， エル．エル．シー． 美容強化のための方法およびシステム
US11235179B2 (en) 2004-10-06 2022-02-01 Guided Therapy Systems, Llc Energy based skin gland treatment
US11724133B2 (en) 2004-10-07 2023-08-15 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
US11207548B2 (en) 2004-10-07 2021-12-28 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
US7571336B2 (en) 2005-04-25 2009-08-04 Guided Therapy Systems, L.L.C. Method and system for enhancing safety with medical peripheral device by monitoring if host computer is AC powered
US20070232986A1 (en) * 2006-03-31 2007-10-04 Cytodome, Inc. Low-profile implantable ultrasound array and method for enhancing drug delivery to tissue
US9566454B2 (en) 2006-09-18 2017-02-14 Guided Therapy Systems, Llc Method and sysem for non-ablative acne treatment and prevention
US20150174388A1 (en) 2007-05-07 2015-06-25 Guided Therapy Systems, Llc Methods and Systems for Ultrasound Assisted Delivery of a Medicant to Tissue
US9216276B2 (en) 2007-05-07 2015-12-22 Guided Therapy Systems, Llc Methods and systems for modulating medicants using acoustic energy
US12102473B2 (en) 2008-06-06 2024-10-01 Ulthera, Inc. Systems for ultrasound treatment
ES2571680T3 (es) 2008-06-06 2016-05-26 Ulthera Inc Sistema para tratamiento cosmético y formación de imágenes
JP2012513837A (ja) 2008-12-24 2012-06-21 ガイデッド セラピー システムズ， エルエルシー 脂肪減少および／またはセルライト処置のための方法およびシステム
US8715186B2 (en) 2009-11-24 2014-05-06 Guided Therapy Systems, Llc Methods and systems for generating thermal bubbles for improved ultrasound imaging and therapy
US10183182B2 (en) 2010-08-02 2019-01-22 Guided Therapy Systems, Llc Methods and systems for treating plantar fascia
US9504446B2 (en) 2010-08-02 2016-11-29 Guided Therapy Systems, Llc Systems and methods for coupling an ultrasound source to tissue
US8857438B2 (en) 2010-11-08 2014-10-14 Ulthera, Inc. Devices and methods for acoustic shielding
WO2013009785A2 (en) 2011-07-10 2013-01-17 Guided Therapy Systems, Llc. Systems and methods for improving an outside appearance of skin using ultrasound as an energy source
KR20140047709A (ko) 2011-07-11 2014-04-22 가이디드 테라피 시스템스, 엘.엘.씨. 조직에 초음파원을 연결하는 시스템 및 방법
US9263663B2 (en) 2012-04-13 2016-02-16 Ardent Sound, Inc. Method of making thick film transducer arrays
US9510802B2 (en) 2012-09-21 2016-12-06 Guided Therapy Systems, Llc Reflective ultrasound technology for dermatological treatments
CN113648551B (zh) 2013-03-08 2025-03-25 奥赛拉公司 用于多焦点超声治疗的装置和方法
US10561862B2 (en) 2013-03-15 2020-02-18 Guided Therapy Systems, Llc Ultrasound treatment device and methods of use
CA2944707C (en) 2014-04-18 2023-01-24 Ulthera, Inc. Band transducer ultrasound therapy
RU2720661C2 (ru) 2016-01-18 2020-05-12 Ультера, Инк. Компактное ультразвуковое устройство, содержащее кольцеобразную ультразвуковую матрицу, электрически соединенную по периферии с гибкой печатной платой, и способ сборки такого устройства
KR20230149878A (ko) 2016-08-16 2023-10-27 얼테라, 인크 이미징 오정렬을 감소시키도록 구성된 초음파 이미징 시스템, 초음파 이미징 모듈 및 이미징 오정렬을 감소시키는 방법
TW202327520A (zh) 2018-01-26 2023-07-16 美商奧賽拉公司 用於多個維度中的同時多聚焦超音治療的系統和方法
US11944849B2 (en) 2018-02-20 2024-04-02 Ulthera, Inc. Systems and methods for combined cosmetic treatment of cellulite with ultrasound
JP7598331B2 (ja) 2019-11-18 2024-12-11 株式会社カネカ 薬液拡散システムおよび薬液拡散促進装置
CN112023243B (zh) * 2020-09-15 2022-03-25 南京大学 超声循环聚焦发射的透皮给药装置及控制方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5016615A (en) * 1990-02-20 1991-05-21 Riverside Research Institute Local application of medication with ultrasound
US5197946A (en) * 1990-06-27 1993-03-30 Shunro Tachibana Injection instrument with ultrasonic oscillating element
US5386837A (en) * 1993-02-01 1995-02-07 Mmtc, Inc. Method for enhancing delivery of chemotherapy employing high-frequency force fields
US5667487A (en) * 1993-04-07 1997-09-16 Henley; Julian L. Ionosonic drug delivery apparatus
US5490840A (en) * 1994-09-26 1996-02-13 General Electric Company Targeted thermal release of drug-polymer conjugates
US5752515A (en) * 1996-08-21 1998-05-19 Brigham & Women's Hospital Methods and apparatus for image-guided ultrasound delivery of compounds through the blood-brain barrier
WO1998018391A1 (en) * 1996-10-30 1998-05-07 Ekos Corporation Intraluminal wall drug delivery device

Also Published As

Publication number Publication date
AU754022B2 (en) 2002-10-31
AU5245099A (en) 2000-02-21
JP2002521118A (ja) 2002-07-16
CA2338396A1 (en) 2000-02-10
EP1107702A1 (en) 2001-06-20
WO2000006032A1 (en) 2000-02-10
EP1107702A4 (en) 2002-10-09

Similar Documents

Publication Publication Date Title
BR9912587A (pt) Processo sistema e dispositivo para realçar a absorção celular de uma substância, processos para realçar a transfecção de gene de um gene transferido para uma região alvo do corpo de um paciente e para promover a angiogênese em membros isquêmicos, e, kit
BR0011856A (pt) Agonistas de receptor a2a de n-pirazol
BR9810500A (pt) Sistema e aparelho para a transferência de ácido nucléico in vivo para o interior de células de organismos eucarióticos pluricelulares
BR9808769A (pt) Construção de gene, uso de uma construção de gene, sistema de dois componentes emparelhados, designado para o uso em um hospedeiro mamìfero, e, processo para transferência de um medicamento citotóxico para um sìtio
BR0010220A (pt) Compostos de pirimidinona
FR16C0028I2 (fr) Vecteurs viraux et utilisation de ces derniers dans des methodes therapeutiques
BR9912653A (pt) Vìrus de herpes atenuado, cepa de vìrus, célula dendrìtica, processo para produzir um célula, composição farmacêutica, uso de um vìrus, e, processo para executar a terapia de gene em um paciente humano ou animal ou para tratar ou prevenir uma infecção patogênica ou câncer para tratar paciente animal
BR9607383A (pt) Composição farmacêutica útil para a transfecção de um ácido nucléico e utilização desta composição
ES2125602T3 (es) Asic de vocoder.
BR0008397A (pt) Processos para acentuar a absorção celular de uma substância suprida para dentro de uma região alvo do corpo de um paciente, para acentuar a transfecção de dna suprido para dentro de uma região alvo do corpo de um paciente, e para inibir hiperplasia ìntima vascular, sistema de suprimento de energia de ultra-som de campo uniforme e feixe largo, conjuntos para acentuar a absorção celular de uma substância suprida para dentro de uma região alvo do corpo de um paciente, para acentuar a transfecção de dna suprido para dentro de uma região alvo do corpo de um paciente, e para inibir hiperplasia ìntima vascular, e, sistema de suprimento de energia de ultra-som de campo uniforme e feixe largo
BR0215785A (pt) dispositivos e metodologias uteis para esteticas do corpo
DK198883D0 (da) Fremgangsmade til fremstilling af menneskevaevs-plasminogenaktivator, dna-sekvens der koder for denne aktivator, replicerbar udtrykkelsesvektor for dna-sekvensen og microorganisme eller cellekultur transformeret med udtrykkelsesvektoren
PE121799A1 (es) Uso de progestina para el control del sangrado
BR0206985A (pt) Anticorpos modificados e métodos de uso
BR0016126A (pt) Agonistas totais ou parciais de a1 derivados n6 heterocìclicos 5'-tio substituìdos de adenosina
DE69733654D1 (de) Anwendung von thermotherapie
DK1021547T3 (da) Vaccineformuleringer indeholdende papillomviruskapsomer og fremgangsmåder til anvendelse heraf
BR0110751A (pt) Dispositivo
DK1011686T3 (da) Modulering af human mastcelleaktivering
DK1024824T3 (da) Dispergerende vaccinesammensætning i fast form til oral indgivelse
BR9713370A (pt) Processos para fabricação de metoprolol e de uma preparação farmacêutica, e, metoprolol
BR9910594A (pt) Vìrus de herpes simplex, uso de um vìrus de herpessimplex, composição farmacêutica e processospara estudar a função de um gene heterólogo emuma célula de mamìfero, para produzir um vìrus deherpes simplex e para tratar um distúrbio ou uma lesãodo sistema nervoso de um mamìfero
ES2023802B3 (es) Procedimiento para producir una atmosfera para el tratamiento de personas reumaticas mediante temperaturas bajas, y una instalacion para el tratamiento del cuerpo entero para realizar este procedimiento
EA200100543A1 (ru) Способ предотвращения развития атеросклероза у млекопитающих
CR6302A (es) Nuevos usos farmaceuticos par inhibidores nos

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 5A , 6A E 7A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1865 DE 03/10/2006.